Jeffrey S. Crippin

7.5k total citations · 1 hit paper
81 papers, 5.2k citations indexed

About

Jeffrey S. Crippin is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Jeffrey S. Crippin has authored 81 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Hepatology, 44 papers in Epidemiology and 32 papers in Surgery. Recurrent topics in Jeffrey S. Crippin's work include Liver Disease Diagnosis and Treatment (31 papers), Liver Disease and Transplantation (30 papers) and Hepatitis C virus research (27 papers). Jeffrey S. Crippin is often cited by papers focused on Liver Disease Diagnosis and Treatment (31 papers), Liver Disease and Transplantation (30 papers) and Hepatitis C virus research (27 papers). Jeffrey S. Crippin collaborates with scholars based in United States, France and United Kingdom. Jeffrey S. Crippin's co-authors include Timothy M. McCashland, Frank Vinholt Schiødt, J. Eileen Hay, William C. Chapman, Grace Samuel, Linda S. Hynan, Anne M. Larson, Timothy J. Davern, George Ostapowicz and A. Obaid Shakil and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of Internal Medicine and Gastroenterology.

In The Last Decade

Jeffrey S. Crippin

79 papers receiving 5.0k citations

Hit Papers

Results of a Prospective ... 2002 2026 2010 2018 2002 500 1000 1.5k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jeffrey S. Crippin United States 31 3.3k 2.6k 1.4k 1.3k 433 81 5.2k
J. Eileen Hay United States 29 2.8k 0.9× 2.1k 0.8× 1.4k 1.0× 1.6k 1.2× 633 1.5× 58 4.7k
Paul H. Hayashi United States 43 3.1k 1.0× 3.3k 1.2× 2.4k 1.7× 1.3k 0.9× 797 1.8× 131 6.6k
Arie Regev United States 34 2.6k 0.8× 2.8k 1.0× 380 0.3× 936 0.7× 285 0.7× 95 4.7k
Jacques Bernuau France 41 3.7k 1.1× 2.9k 1.1× 1.0k 0.8× 1.7k 1.3× 288 0.7× 140 5.5k
Marwan Ghabril United States 35 1.9k 0.6× 1.7k 0.6× 760 0.5× 1.4k 1.0× 754 1.7× 199 4.4k
Timothy M. McCashland United States 30 3.0k 0.9× 2.4k 0.9× 1.5k 1.1× 1.7k 1.3× 812 1.9× 63 5.2k
Adrian Reuben United States 38 1.9k 0.6× 2.0k 0.8× 976 0.7× 1.3k 0.9× 793 1.8× 140 4.6k
Nikolaos Pyrsopoulos United States 25 2.4k 0.7× 2.7k 1.0× 518 0.4× 680 0.5× 244 0.6× 120 4.1k
Alexander Gimson United Kingdom 45 4.5k 1.4× 2.7k 1.0× 1.0k 0.7× 3.3k 2.5× 171 0.4× 100 6.5k
Georg Auzinger United Kingdom 36 3.1k 1.0× 2.2k 0.8× 1.6k 1.2× 1.5k 1.1× 179 0.4× 112 5.0k

Countries citing papers authored by Jeffrey S. Crippin

Since Specialization
Citations

This map shows the geographic impact of Jeffrey S. Crippin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey S. Crippin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey S. Crippin more than expected).

Fields of papers citing papers by Jeffrey S. Crippin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffrey S. Crippin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey S. Crippin. The network helps show where Jeffrey S. Crippin may publish in the future.

Co-authorship network of co-authors of Jeffrey S. Crippin

This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey S. Crippin. A scholar is included among the top collaborators of Jeffrey S. Crippin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey S. Crippin. Jeffrey S. Crippin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Aliabadi‐Wahle, Shaghayegh, et al.. (2023). Transgender Males on Gender-Affirming Hormone Therapy and Hepatobiliary Neoplasms: A Systematic Review. Endocrine Practice. 29(10). 822–829. 5 indexed citations
2.
Chen, Jacqueline, et al.. (2021). Increased Risk of Advanced Colonic Adenomas and Timing of Surveillance Colonoscopy Following Solid Organ Transplantation. Digestive Diseases and Sciences. 67(5). 1858–1868. 2 indexed citations
3.
Khan, Adeel, Neeta Vachharajani, Jason R. Wellen, et al.. (2020). Liver transplantation for hepatitis C patients in the era of direct-acting antiviral treatment: A retrospective cohort study. International Journal of Surgery. 75. 84–90. 8 indexed citations
4.
Chen, Alexander, et al.. (2016). Indwelling Tunneled Pleural Catheters for the Management of Hepatic Hydrothorax. A Pilot Study. Annals of the American Thoracic Society. 13(6). 862–866. 50 indexed citations
5.
Ramachandran, Sabarinathan, Haseeb Ilias Basha, Nayan J. Sarma, et al.. (2013). Hepatitis C Virus Induced miR200c Down Modulates FAP-1, a Negative Regulator of Src Signaling and Promotes Hepatic Fibrosis. PLoS ONE. 8(8). e70744–e70744. 42 indexed citations
6.
Rude, Mary K., et al.. (2013). Recurrent Hepatic Epithelioid Hemangioendothelioma After Orthotopic Liver Transplantation. Hepatology. 59(5). 2050–2052. 8 indexed citations
7.
Ma, Changqing, Jeffrey S. Crippin, William C. Chapman, et al.. (2013). Parenchymal alterations in cirrhotic livers in patients with hepatopulmonary syndrome or portopulmonary hypertension. Liver Transplantation. 19(7). 741–750. 4 indexed citations
8.
Subramanian, Vijay, Ankit Bharat, Neeta Vachharajani, et al.. (2013). Perioperative blood transfusion affects hepatitis C virus (HCV)-specific immune responses and outcome following liver transplantation in HCV-infected patients. HPB. 16(3). 282–294. 5 indexed citations
9.
Bowman, Lyndsey J., et al.. (2012). Once weekly fluconazole for antifungal prophylaxis post‐liver transplantation. HPB. 15(7). 541–547. 3 indexed citations
10.
Seetharam, Anil B., Brian B. Borg, Vijay Subramanian, et al.. (2011). Temporal Association Between Increased Virus-Specific Th17 Response and Spontaneous Recovery From Recurrent Hepatitis C in a Liver Transplant Recipient. Transplantation. 92(12). 1364–1370. 15 indexed citations
11.
Basha, Haseeb Ilias, Vijay Subramanian, Anil B. Seetharam, et al.. (2011). Characterization of HCV-Specific CD4+Th17 Immunity in Recurrent Hepatitis C–Induced Liver Allograft Fibrosis. American Journal of Transplantation. 11(4). 775–785. 30 indexed citations
12.
Hong, Barry A., et al.. (2010). The Psychiatric Diagnosis of Alcohol Abuse and the Medical Diagnosis of Alcoholic Related Liver Disease: Effects on Liver Transplant Survival. Journal of Clinical Psychology in Medical Settings. 17(3). 195–202. 9 indexed citations
13.
Gordon, Fredric D., Paul Y. Kwo, R. Ghalib, et al.. (2010). 23 PEGINTERFERON ALFA-2B AND RIBAVIRIN FOR HEPATITIS C RECURRENCE POST ORTHOTOPIC LIVER TRANSPLANTATION (OLT): FINAL RESULTS FROM THE PROTECT STUDY. Journal of Hepatology. 52. S10–S11.
14.
Crippin, Jeffrey S.. (2006). Is Tube Feeding an Option in Patients With Liver Disease?. Nutrition in Clinical Practice. 21(3). 296–298. 10 indexed citations
15.
Drechsler, Henning, et al.. (2003). Management of Chronic Hepatitis B in an HIV-Positive Patient with 3TC-Resistant Hepatitis B Virus. AIDS Patient Care and STDs. 17(9). 439–442. 5 indexed citations
16.
Crippin, Jeffrey S., Timothy M. McCashland, Norah A. Terrault, Patricia A. Sheiner, & Michael R. Charlton. (2002). A pilot study of the tolerability and efficacy of antiviral therapy in hepatitis C virus-infected patients awaiting liver transplantation. Liver Transplantation. 8(4). 350–355. 241 indexed citations
18.
Jeyarajah, D. Rohan, George J. Netto, Stephen P. Lee, et al.. (1998). RECURRENT PRIMARY SCLEROSING CHOLANGITIS AFTER ORTHOTOPIC LIVER TRANSPLANTATION. Transplantation. 66(10). 1300–1306. 94 indexed citations
19.
Ricci, P, Terry M. Therneau, Michael Malinchoc, et al.. (1997). A Prognostic Model for the Outcome of Liver Transplantation in Patients With Cholestatic Liver Disease. Hepatology. 25(3). 672–677. 78 indexed citations
20.
Crippin, Jeffrey S., et al.. (1994). RETRANSPLANTATION IN HEPATITIS B—A MULTICENTER EXPERIENCE1. Transplantation. 57(6). 823–825. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026